Nuevas recomendaciones sobre el uso de corticoides en el paciente crítico

Djillali Annane, Stephen M. Pastores, Bram Rochwerg, Wiebke Arlt, Robert A. Balk, Albertus Beishuizen, et al. Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I and II). Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017

  • Isabel De la Calle Gil Médico Residente. Unidad de Cuidados Intensivos de Anestesia. Hospital Universitario 12 de Octubre. Madrid.
  • Estefanía Carvajal Revuelta Médico Residente. Unidad de Cuidados Intensivos de Anestesia. Hospital Universitario 12 de Octubre. Madrid.
  • Raquel García Álvarez Médico Adjunto. Unidad de Cuidados Intensivos de Anestesia. Hospital Universitario 12 de Octubre. Madrid.
Palabras clave: críticos, paciente crítico, corticoides, guías, formación, CIRCI, critical, critical patient, corticosteroids, guides, learning, critical illness‑related corticosteroid insufficiency (CIRCI)

Resumen

La utilización de corticoides en el paciente crítico es una práctica clínica habitual, aunque no siempre respaldada por la evidencia científica. Los datos aportados por estas nuevas guías intentan responder a algunas de las dudas que se nos plantean diariamente en el ejercicio de nuestra actividad.

ABSTRACT

 The use of corticosteroids in critically ill patients is a common clinical practice, although not always supported by scientific evidence. The recommendations provided by these new guides try to answer some ot the questions tha we have to face daily in the exercise of our activity.

Citas

Djillali Annane, Stephen M. Pastores, Wiebke Arlt, Robert A. Balk, Albertus Beishuizen, Josef Briegel, Joseph Carcillo, Mirjam Christ‑Crain, Mark S. Cooper, Paul E. Marik, Gianfranco Umberto Meduri, Keith M. Olsen, Bram Rochwerg, Sophia C. Rodgers, James A. Russell and Greet Van den Berghe. Critical illness‑related corticosteroid insufficiency (CIRCI): a narrative review from a Multispecialty Task Force of the SCCM and ESICM.

Rhodes A et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Critical Care Med 2017; 45 (3): 486-552.

Dellinger R.P., M.M. Levy, JM Carlet, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2012. Critical Care Med 2013 Feb; 41(2): 580-637

Dellinger R.P., M.M. Levy, JM Carlet, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2008. Critical Care Medicine 2008 Jan;36(1):296-327.

Venkatesh B et al. Adjunctive glucocorticoid therapy in patients with Septic Shock. ADRENAL Trial Investigators and the Australian–New Zealand Intensive Care Society Clinical Trials Group. N Engl J Med. 2018 Jan 19

Herrán. Monge R., et al. Epidemiology and Changes in Mortality of Sepsis after the Implementation of Surviving Sepsis, Campaign Guidelines. J. Intensive Care Med 2017 Jan.

Ranieri VM, et al. Acute respiratory distress syndrome: the Berlin definition. JAMA 2012 Jun 20;307 (23):2526-33

Ruan SY, Lin HH, Huang ChT. Exploring the heterogeneity of effecs of corticosteroids on acute respiratory distress syndrome: a systematic review and meta-analysis. Critical Care 2014,18:R63.

Meduri GU, Bridges L, Shin MC et al. Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients’ data from four randomized trials and trial-level metaanalysis of the updated literature. Intensive Care Med (2016) 42(5):829–840

Stern A, Skalsky K, Avni T, Carrara E, Leibovici L, Paul M. Corticosteroids for pneumonia. Cochrane Database of Systematic Reviews. 2017, 12

Jesse W. Delaney, Ruxandra Pintor et. al. and on behalf of the Canadian Critical Care Trials Group H1N1 Collaborative. Delaney et al. The influence of corticosteroid treatment on the outcome of influenza A (H1N1pdm09)-related critical illness. Critical Care (2016) 20:75

Brouwer MC, McIntyre P, Prasad K, van de Beek D. Corticosteroids for acute bacterial meningitis. Cochrane Database of Systematic Reviews 2013, Issue 6. Art. No.: CD004405.

Tsai MS, Chuang PY, et al. Glucocorticoid use during cardiopulmonary resucitation may be beneficial for cardiac arrest. International Journal of Cardiology 2016 Nov 1;222:629-35.

Botnaru T, Altherwi T, Dankoff J. Improved neurologic outcomes after cardiac arrest with combined administration of vasopressin, steroids, and epinephrine compared to epinephrine alone. CJEM. 2015 Mar;17(2):202-5

Whitlock RP, Chan S, Devereaux PJ, et al. Clinical benefit of steroid use in patients undergoing cardiopulmonary bypas: a meta-analysis of randomized trials. Eur Heart J 2008;29: 2592–600.

Dieleman JM, Nierich AP, Rosseel PM et al. Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial. JAMA 308:1761–1767. 2012

Whitlock RP, Devereaux PJ, Teoh KH et al. Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial. Lancet 386(10000):1243–1253.2015
Publicado
30-11-2018
Cómo citar
De la Calle Gil, I., Carvajal Revuelta, E., & García Álvarez, R. (2018). Nuevas recomendaciones sobre el uso de corticoides en el paciente crítico. Revista Electrónica AnestesiaR, 10(11), 6. https://doi.org/https://doi.org/10.30445/rear.v10i11.649
Sección
Lectura crítica de artículos